Articles tagged with "REMICADE (infliximab)"

FDA Approves Amgen’s Infliximab Biosimilar Treatment

December 10, 2019 • By Reuters Staff

Study Says 1 Biosimilar Switch Is OK; Jury Still Out on Multiple Switches

August 17, 2018 • By Thomas R. Collins

Health Plans Enact Coverage Policies for Remicade & Infliximab Biosimilars

February 16, 2018 • By From the College

Pfizer’s Second Biosimilar of J&J’s Remicade Wins U.S. FDA Approval

December 14, 2017 • By Tamara Mathias

Pfizer Files Suit Against J and J over Remicade Contracts

September 20, 2017 • By Caroline Humer

U.K. Competition Watchdog Accuses Merck of Obstructing Biosimilars

May 23, 2017 • By Ben Hirschler

Pfizer Announces Medicare Reimbursement for Inflectra (infliximab-dyyb), the First Biosimilar Monoclonal Antibody Available in the United States

January 13, 2017 • By Pfizer